| Product Code: ETC8633809 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria RNAI Therapeutics Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria RNAI Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria RNAI Therapeutics Market - Industry Life Cycle |
3.4 Nigeria RNAI Therapeutics Market - Porter's Five Forces |
3.5 Nigeria RNAI Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Nigeria RNAI Therapeutics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Nigeria RNAI Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Nigeria |
4.2.2 Growing awareness and adoption of RNAi therapeutics as a treatment option |
4.2.3 Favorable government initiatives and policies to support healthcare advancements in Nigeria |
4.3 Market Restraints |
4.3.1 High cost associated with RNAi therapeutics may limit accessibility for a large portion of the population |
4.3.2 Limited infrastructure and resources for research and development of RNAi therapeutics in Nigeria |
5 Nigeria RNAI Therapeutics Market Trends |
6 Nigeria RNAI Therapeutics Market, By Types |
6.1 Nigeria RNAI Therapeutics Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Nigeria RNAI Therapeutics Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 Nigeria RNAI Therapeutics Market Revenues & Volume, By Intradermal Injections, 2021- 2031F |
6.1.4 Nigeria RNAI Therapeutics Market Revenues & Volume, By Pulmonary Delivery, 2021- 2031F |
6.1.5 Nigeria RNAI Therapeutics Market Revenues & Volume, By Intravenous Injections, 2021- 2031F |
6.1.6 Nigeria RNAI Therapeutics Market Revenues & Volume, By Intraperitoneal Injections, 2021- 2031F |
6.1.7 Nigeria RNAI Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Nigeria RNAI Therapeutics Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 Nigeria RNAI Therapeutics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.2.3 Nigeria RNAI Therapeutics Market Revenues & Volume, By Research and Academic Laboratories, 2021- 2031F |
6.2.4 Nigeria RNAI Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
7 Nigeria RNAI Therapeutics Market Import-Export Trade Statistics |
7.1 Nigeria RNAI Therapeutics Market Export to Major Countries |
7.2 Nigeria RNAI Therapeutics Market Imports from Major Countries |
8 Nigeria RNAI Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for RNAi therapeutics in Nigeria |
8.2 Percentage increase in healthcare expenditure allocated to RNAi therapeutics research and development |
8.3 Number of partnerships and collaborations between local and international pharmaceutical companies for RNAi therapeutics development |
9 Nigeria RNAI Therapeutics Market - Opportunity Assessment |
9.1 Nigeria RNAI Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Nigeria RNAI Therapeutics Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Nigeria RNAI Therapeutics Market - Competitive Landscape |
10.1 Nigeria RNAI Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Nigeria RNAI Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |